Sign In

Login

Password

Forgot Password ? Sign Up

تيزيبيلوماب (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "تيزيبيلوماب" in Arabic language version.

refsWebsite
Global rank Arabic rank
9web.archive.org
1st place
1st place
5nih.gov
4th place
6th place
3doi.org
2nd place
5th place
3astrazeneca.com
low place
low place
2semanticscholar.org
11th place
86th place
2fda.gov
447th place
393rd place
1harvard.edu
18th place
33rd place
1canada.ca
1,712th place
2,385th place
1hres.ca
low place
low place
1europa.eu
68th place
91st place

astrazeneca.com

canada.ca

health-products.canada.ca

doi.org

  • Verstraete K، Peelman F، Braun H، Lopez J، Van Rompaey D، Dansercoer A، وآخرون (أبريل 2017). "Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma". Nature Communications. ج. 8 ع. 1: 14937. Bibcode:2017NatCo...814937V. DOI:10.1038/ncomms14937. PMC:5382266. PMID:28368013.
  • Marone G، Spadaro G، Braile M، Poto R، Criscuolo G، Pahima H، وآخرون (نوفمبر 2019). "Tezepelumab: a novel biological therapy for the treatment of severe uncontrolled asthma". Expert Opinion on Investigational Drugs. ج. 28 ع. 11: 931–940. DOI:10.1080/13543784.2019.1672657. PMID:31549891. S2CID:202746054.
  • Matera MG، Rogliani P، Calzetta L، Cazzola M (فبراير 2020). "TSLP Inhibitors for Asthma: Current Status and Future Prospects". Drugs. ج. 80 ع. 5: 449–458. DOI:10.1007/s40265-020-01273-4. PMID:32078149. S2CID:211194472.

europa.eu

ema.europa.eu

  • "Tezspire EPAR". European Medicines Agency. 19 يوليو 2022. مؤرشف من الأصل في 2022-09-22. اطلع عليه بتاريخ 2022-09-21. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

fda.gov

harvard.edu

ui.adsabs.harvard.edu

  • Verstraete K، Peelman F، Braun H، Lopez J، Van Rompaey D، Dansercoer A، وآخرون (أبريل 2017). "Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma". Nature Communications. ج. 8 ع. 1: 14937. Bibcode:2017NatCo...814937V. DOI:10.1038/ncomms14937. PMC:5382266. PMID:28368013.

hres.ca

hpr-rps.hres.ca

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Verstraete K، Peelman F، Braun H، Lopez J، Van Rompaey D، Dansercoer A، وآخرون (أبريل 2017). "Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma". Nature Communications. ج. 8 ع. 1: 14937. Bibcode:2017NatCo...814937V. DOI:10.1038/ncomms14937. PMC:5382266. PMID:28368013.
  • Marone G، Spadaro G، Braile M، Poto R، Criscuolo G، Pahima H، وآخرون (نوفمبر 2019). "Tezepelumab: a novel biological therapy for the treatment of severe uncontrolled asthma". Expert Opinion on Investigational Drugs. ج. 28 ع. 11: 931–940. DOI:10.1080/13543784.2019.1672657. PMID:31549891. S2CID:202746054.
  • Matera MG، Rogliani P، Calzetta L، Cazzola M (فبراير 2020). "TSLP Inhibitors for Asthma: Current Status and Future Prospects". Drugs. ج. 80 ع. 5: 449–458. DOI:10.1007/s40265-020-01273-4. PMID:32078149. S2CID:211194472.

ncbi.nlm.nih.gov

  • Verstraete K، Peelman F، Braun H، Lopez J، Van Rompaey D، Dansercoer A، وآخرون (أبريل 2017). "Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma". Nature Communications. ج. 8 ع. 1: 14937. Bibcode:2017NatCo...814937V. DOI:10.1038/ncomms14937. PMC:5382266. PMID:28368013.

dailymed.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

web.archive.org